Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRI vs mFOLFOX6 Adjuvant Therapy in Advanced Colorectal Cancer
NCT01566942Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2012
- Primary completion
- May 2014
- Modality
- Nanoparticles, Monoclonal Antibodies, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab in colorectal cancer (CRC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01566942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01566942.